Axon Enterprise, Inc $AXON Stock Position Lifted by Eventide Asset Management LLC

Eventide Asset Management LLC boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 2.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 70,702 shares of the biotechnology company’s stock after acquiring an additional 1,598 shares during the period. Eventide Asset Management LLC’s holdings in Axon Enterprise were worth $40,159,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $480,000. NewEdge Advisors LLC raised its stake in shares of Axon Enterprise by 41.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC raised its stake in shares of Axon Enterprise by 8.4% during the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after purchasing an additional 157 shares in the last quarter. Woodline Partners LP raised its position in Axon Enterprise by 40.6% during the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after acquiring an additional 2,003 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Axon Enterprise in the second quarter valued at approximately $284,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 564 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $478.97, for a total transaction of $270,139.08. Following the completion of the sale, the director owned 3,632 shares of the company’s stock, valued at $1,739,619.04. This represents a 13.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the sale, the insider directly owned 34,024 shares of the company’s stock, valued at $16,501,640. The trade was a 4.37% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 39,344 shares of company stock valued at $19,267,315. Insiders own 4.20% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Needham & Company LLC reduced their target price on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a research note on Friday, February 20th. Wall Street Zen raised shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. TD Cowen decreased their price objective on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a report on Wednesday, April 8th. Citizens Jmp decreased their price objective on shares of Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating for the company in a report on Thursday, May 7th. Finally, Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Stock Down 1.0%

Shares of Axon Enterprise stock opened at $441.73 on Friday. The stock has a market capitalization of $35.60 billion, a P/E ratio of 177.40, a PEG ratio of 8.03 and a beta of 1.45. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The stock has a 50 day moving average price of $410.34 and a two-hundred day moving average price of $489.19. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company’s revenue was up 33.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.47 earnings per share. Equities analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.